Metoxamina [Inn-Spanish] en es it fr

Metoxamina [Inn-Spanish] Brand names, Metoxamina [Inn-Spanish] Analogs

Metoxamina [Inn-Spanish] Brand Names Mixture

  • No information avaliable

Metoxamina [Inn-Spanish] Chemical_Formula

C11H17NO3

Metoxamina [Inn-Spanish] RX_link

No information avaliable

Metoxamina [Inn-Spanish] fda sheet

Metoxamina [Inn-Spanish] msds (material safety sheet)

Metoxamina_[Inn-Spanish] MSDS

Metoxamina [Inn-Spanish] Synthesis Reference

No information avaliable

Metoxamina [Inn-Spanish] Molecular Weight

211.258 g/mol

Metoxamina [Inn-Spanish] Melting Point

No information avaliable

Metoxamina [Inn-Spanish] H2O Solubility

Soluble (185 g/L)

Metoxamina [Inn-Spanish] State

Solid

Metoxamina [Inn-Spanish] LogP

1.5

Metoxamina [Inn-Spanish] Dosage Forms

Liquid

Metoxamina [Inn-Spanish] Indication

Indicated for the treatment and management of hypotension.

Metoxamina [Inn-Spanish] Pharmacology

Methoxamine is a potent sympathomimetic amine that increases both systolic and diastolic blood pressure. Methoxamine is indicated for prevention and treatment of the acute hypotensive state occurring with spinal anesthesia. It is also indicated as adjunctive treatment of hypotension due to hemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to trauma or tumor. Methoxamine acts on both α1-adrenergic receptors but appears to have no effect on β-adrenergic receptors. It acts by increasing the force of the heart's pumping action as well as constricting peripheral blood vessels.

Metoxamina [Inn-Spanish] Absorption

No information avaliable

Metoxamina [Inn-Spanish] side effects and Toxicity

No information avaliable

Metoxamina [Inn-Spanish] Patient Information

No information avaliable

Metoxamina [Inn-Spanish] Organisms Affected

Humans and other mammals